Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 69.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 66.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 75.0 | 47 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | LIF | 98.0 | 68 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | LIF | 214.0 | 64 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 117.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 100.0 | 67 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 115.0 | 51 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 88.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 105.0 | 73 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | LIF | 132.0 | 63 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | LIF | 281.5 | 70 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 170.5 | 44 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 184.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 310.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 274.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 137.5 | 62 | |
RA2159 | PI103 | 0.1 | uM | 3 | LIF | 76.5 | 52 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | LIF | 571.5 | 72 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 440.5 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 506.5 | 66 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 651.5 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 198.0 | 43 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | LIF | 314.5 | 74 | |
N2586 | PI103 | 0.1 | uM | 3 | LIF | 95.0 | 59 |